Niagen Bioscience Inc

NASDAQ: NAGE · Real-Time Price · USD
10.01
0.30 (3.09%)
At close: Aug 15, 2025, 3:59 PM
10.05
0.40%
After-hours: Aug 15, 2025, 07:52 PM EDT

Niagen Bioscience Inc Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
44.51M 27.17M 20.29M 28.02M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
368K 383K 497K 723K
Receivables
7.77M 5.23M 8.48M 5.23M
Inventory
9.19M 14.53M 14.68M 13.6M
Other Current Assets
1.05M 2.6M 3.12M 200K
Total Current Assets
64.1M 49.53M 46.57M 48.91M
Property-Plant & Equipment
3.45M 4.54M 6.32M 7.36M
Goodwill & Intangibles
359K 510K 671K 857K
Total Long-Term Assets
4.18M 5.43M 7.49M 8.94M
Total Assets
68.28M 54.96M 54.06M 57.84M
Account Payables
8.53M 10.23M 9.68M 10.42M
Deferred Revenue
611K 195K 157K 161K
Short-Term Debt
994K 702K 696K 548K
Other Current Liabilities
-994K -702K -696K -548K
Total Current Liabilities
17.95M 20.62M 17.87M 17.61M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
4.24M 5.89M 7.52M 8.5M
Total Liabilities
22.18M 26.51M 25.39M 26.11M
Total Debt
2.65M 3.28M 4.26M 4.7M
Common Stock
77K 75K 74K 68K
Retained Earnings
-181.91M -190.46M -185.49M -168.95M
Comprehensive Income
-4K -4K -3K -2K
Shareholders Equity
46.09M 28.46M 28.67M 31.73M
Total Investments
n/a n/a n/a n/a